Vimarsana
Biggest News Aggregation in the World

Extend Response Results News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Extend Response Results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Extend Response Results Today - Breaking & Trending Today

Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice - Vimarsana News

Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice

Published: May 16, 2024

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Source: prnewswire.com
Related Topics:
United StatesUnited KingdomBrian PoligoneJournal Of The European Academy DermatologyOur Public Health SolutionsDevelopment AuthorityJournal Of The American Medical AssociationSoligenix IncExchange CommissionNational Institute Of AllergyDrug AdministrationEurope European UnionEuropean Medicines AgencyRochester Skin Lymphoma Medical GroupUs CongressBiomedical Advanced ResearchDefense Threat Reduction AgencyPublished Results ConfirmExtend Response ResultsEuropean AcademyComposite AssessmentIndex Lesion SeverityAmerican Medical AssociationPrincipal InvestigatorLeading Enrolling Investigator
Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte™ in the Treatment of Cutaneous T-Cell Lymphoma - Vimarsana News

Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte™ in the Treatment of Cutaneous T-Cell Lymphoma

Published: May 4, 2023

Results Confirm and Extend Response Results from Phase 3 FLASH Study PRINCETON, N.J., May 4, 2023 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and... | May 4, 2023

Source: marketscreener.com
Related Topics:
Brian PoligoneChristopherj SchaberDrug AdministrationExchange CommissionDevelopment AuthorityPrnewswire Soligenix IncUs CongressDefense Threat Reduction AgencyEuropean Medicines AgencyWhile The CompanyBiomedical Advanced ResearchUs DevelopmentSoligenix IncNational Institute Of AllergyOur Public Health SolutionsRochester Skin Lymphoma Medical GroupResults ConfirmExtend Response ResultsDaavlin SeriesComposite AssessmentIndex Lesion SeverityRochester Skin Lymphoma MedicalPrincipal InvestigatorLeading Enrolling InvestigatorChief Executive Officer